Advanced search
Publication Cover
Current Medical Research and Opinion Volume 35, 2019 - Issue 2
Submit an article Journal homepage
1,267
Views
3
CrossRef citations to date
0
Altmetric
Respiratory

Patient perception of Breezhaler® and Ellipta® device feedback mechanisms in COPD: The ADVANTAGE Study

Pablo AltmanGlobal Med Affairs – Respiratory, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA; Correspondence[email protected]
,
Miguel A. BergnaRespiratory Research, CEMER Centro Médico de Enfermedades Respiratorias, Buenos Aires, Argentina;
,
Gabriel R. GarciaPneumology, Cenasma Institute, Buenos Aires, Argentina;
,
Tadhg GuerinNovartis Product Lifecycle Services, Novartis Pharmaceuticals & Novartis Global Services Center, Dublin, Ireland;
,
Andrea V. PinoRespiratory Franchise, Novartis Argentina SA, Buenos Aires, Argentina
&
John L. WhitefordNovartis Product Lifecycle Services, Novartis Pharmaceuticals & Novartis Global Services Center, Dublin, Ireland;
Pages 221-227 | Received 26 Oct 2017, Accepted 20 Feb 2018, Published online: 15 May 2018

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Luis Perez de Llano, Elsa Naval, Natalia Mejía & Javier Domínguez-Ortega. (2022) Inhaled indacaterol/glycopyrronium/mometasone furoate fixed-dose combination in moderate-to-severe asthma. Expert Review of Respiratory Medicine 16:1, pages 1-15.
Read now

Articles from other publishers (2)

Jutta Beier, Henrik Watz, Zuzana Diamant, Jens M. Hohlfeld, Dave Singh, Pascale Pinot, Ieuan Jones & Hanns-Christian Tillmann. (2021) Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trial. ERJ Open Research 7:2, pages 00425-2020.
Crossref
Anthony D’Urzo, Kenneth R. Chapman, James F. Donohue, Peter Kardos, M. Reza Maleki-Yazdi & David Price. (2019) Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD. Pulmonary Therapy 5:1, pages 23-41.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.